Kotak Fund to invest ₹1,600 crore in Nimmagadda Prasad's API business

Kotak Strategic Situations Fund (KSSF) plans to invest around ₹1,600 crore in the active pharmaceutical ingredients (API) business acquired by Nimmagadda Prasad. The fund will support the acquisition through a $200 million funding, provided through a mix of structured debt and equity. Deutsche Bank and DBS have also reportedly financed the acquisition.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bqoK9rf
via IFTTT